|
KR0162983B1
|
|
Novel antimicrobial quinolonyl lactam esters
|
|
US5273973A
|
|
Antimicrobial quinolonyl esters
|
|
US5260073A
|
|
Use of phenylpropanolamine as a mucus secretogogue in the upper airways
|
|
IL101832D0
|
|
Methylene phosphonoalkyl-phosphinates and pharmaceutical compositions containing them
|
|
IL101833D0
|
|
Methylene phosphonoalkyl-phosphinates and pharmaceutical compositions containing them
|
|
IL101834D0
|
|
Methylene phosphonoalkyl-phosphinates and pharmaceutical compositions containing them
|
|
US5214042A
|
|
Use of 5-phenyl-2-furan esters, amides and ketones as neuroprotective agents
|
|
CZ175593A3
|
|
Pharmaceutical preparation for treating osteoporosis
|
|
WO9216214A1
|
|
The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d)
|
|
IL98179D0
|
|
Pharmaceutical compositions containing phenylpropanolamine
|
|
US5180719A
|
|
Antimicrobial quinolonyl lactam esters
|
|
EG20532A
|
|
Process for preparing of novel antimicrobial quinolonyl lactams
|
|
ZA9002433B
|
|
Child resistant container for storing hazardous materials
|
|
CA2002299A1
|
|
Compositions for the transdermal delivery of buprenorphine salts
|
|
JP2875015B2
|
|
New antimicrobial agents dithiocarbamoylquinolones
|
|
IE893430L
|
|
Antimicrobial quinolonyl lactams
|
|
IE893432L
|
|
Dithiocarbamoyl quinolones
|
|
IE893429L
|
|
Lactams
|
|
IE893431L
|
|
Novel antimicrobial lactam quinolones
|
|
IE893428L
|
|
Cephalosporin compounds
|
